NCT04713982: Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease |
|
|
| Recruiting | 2/3 | 30 | US | Deutetrabenazine, Austedo | Vanderbilt University Medical Center, Teva Branded Pharmaceutical Products R&D, Inc. | Huntington Disease | 08/25 | 04/26 | | |